Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 224-069-3 | CAS number: 4191-73-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
LD50 was considered to be > 2000 mg/kg bw when DDY male mice were treated with isopropyl 4-hydroxybenzoate orally.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Justification for type of information:
- Data is from peer-reviewed journal
- Qualifier:
- according to guideline
- Guideline:
- other: as below
- Principles of method if other than guideline:
- Acute oral toxicity study of isopropyl 4-hydroxybenzoate in mice to set the appropriate dose of each chemical for the comet assay
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- yes
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): Isopropyl Paraben (isopropyl 4-hydroxybenzoate)
- Molecular formula (if other than submission substance): C10H12O3
- Molecular weight (if other than submission substance): 180.202 g/mole
- Substance type: Organic
- Physical state: Solid
Purity >99.0% - Species:
- mouse
- Strain:
- other: DDY
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Source: Japan SLC Co., Shizuoka, Japan
Age at study initiation: 8 weeks
Weight at study initiation: no data available
Fasting period before study: no data available
Housing: no data available
Diet (e.g. ad libitum): commercial pellets MF (Oriental Yeast Industries Co., Tokyo, Japan), ad libitum
Water (e.g. ad libitum): Tap Water, ad libitum
Acclimation period: 1 week of acclimatization
ENVIRONMENTAL CONDITIONS
Temperature (°C): The animal room was at 20–24°C
Humidity (%): No data
Air changes (per hr): No data
Photoperiod (hrs dark / hrs light): 12 h light–dark cycle. - Route of administration:
- oral: gavage
- Vehicle:
- olive oil
- Details on oral exposure:
- Details on exposure
VEHICLE
- Concentration in vehicle: 2000 mg/kg bw
- Amount of vehicle (if gavage): No data available
- Justification for choice of vehicle:olive oil
- Lot/batch no. (if required):No data available
- Purity:No data available
MAXIMUM DOSE VOLUME APPLIED: No data available
DOSAGE PREPARATION (if unusual): Dose were prepared in olive oil
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: In order to set the appropriate dose of each chemical for the comet assay, 0.5 × LD50 or the limit dose of 2000 mg/kg were given to mice. - Doses:
- 2000 mg/kg bw
- No. of animals per sex per dose:
- 4-5 male mice
- Control animals:
- not specified
- Details on study design:
- - Other examinations performed: Mortality were observed.
- Statistics:
- not specified
- Preliminary study:
- not specified
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No mortality observed
- Mortality:
- No mortality was observed in treated male mice at 2000 mg/kg bw
- Clinical signs:
- other: not specified
- Gross pathology:
- not specified
- Other findings:
- not specified
- Interpretation of results:
- Category 5 based on GHS criteria
- Conclusions:
- LD50 was considered to be > 2000 mg/kg bw when DDY male mice were treated with isopropyl 4-hydroxybenzoate orally.
- Executive summary:
In a acute oral toxicity study, DDY male mice were treated with isopropyl 4-hydroxybenzoate in the limit dose of 2000 mg/kg bw orally in Olive Oil. No mortality was observed in treated male mice at 2000 mg/kg bw. Therefore, LD50 was considered to be > 2000 mg/kg bw when DDY male mice were treated with isopropyl 4-hydroxybenzoate orally.
Reference
Test chemical |
Vehicle |
Source* |
LD50** mg/kg |
p-Hydroxybenzoic acid iso-propyl ester |
Olive oil |
T |
>2000 |
*T = Tokyo Kasei Kogyo Industry Ltd., Tokyo, Japan;
** In order to set appropriate doses for the assay, we determined approximate LD50 by simple acute toxicity experiments on four–five animals. When no death was observed at 2000 mg/kg, the LD50 was defined as >2000 mg/kg.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Data is Klimisch 2 and from peer-reviewed journal
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Acute oral toxicity:
In different studies, isopropyl 4-hydroxybenzoatehas been investigated for acute oral toxicity to a greater or lesser extent. Often are the studies based on in vivo experiments and estimated data in rodents, i.e. most commonly in mice and rats for isopropyl 4-hydroxybenzoate along with the study available on structurally similar read across substance Butylparaben (CAS no 94-26-8). The predicted data using the OECD QSAR toolbox has also been compared with the experimental studies.
In a experimental study conducted by Sasaki et al (Mutation Research 519 (2002) 103–119), DDY male mice were treated with isopropyl 4-hydroxybenzoate in the limit dose of 2000 mg/kg bw orally in Olive Oil. No mortality was observed in treated male mice at 2000 mg/kg bw. Therefore, LD50 was considered to be > 2000 mg/kg bw when DDY male mice were treated with isopropyl 4-hydroxybenzoate orally.
In another prediction done by SSS (2017) using the OECD QSAR toolbox with log kow as the primary descriptor, the acute oral toxicity was estimated for isopropyl 4-hydroxybenzoate. The LD50 was estimated to be 5799 mg/kg bw for rats.
Also it is further supported by experimental studies summarized by Andersen et al (International Journal of Toxicology, 2008, vol. 27, pp. 1-82, SUP4,) on structurally similar read across substance Butylparaben (CAS no 94-26-8), rat were treated with Butylparaben in the concentration of 5000 and 25000 mg/kg bw as 0.2 % or 0.3 % orally. No deaths were observed in treated rat at 5000 and 25000 mg/kg bw. Therefore, LD50 was considered to be > 5000 and 25000 mg/kg bw when rat were treated with Butylparaben orally.
Thus, based on the above studies and predictions on isopropyl 4-hydroxybenzoate and its read across substances, it can be concluded that LD50 value is greater than 2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, isopropyl 4-hydroxybenzoate can be “Not classified” as acute oral toxicity.
Justification for classification or non-classification
Based on the above studies and predictions on isopropyl 4-hydroxybenzoate and its read across substances, it can be concluded that LD50 value is greater than 2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, isopropyl 4-hydroxybenzoate can be “Not classified” as acute oral toxicity.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
